Birth control in perimenopause: options and when to stop

You can get pregnant in perimenopause. Ovulation becomes irregular, not absent, and periods can return after months away. US guidance is to keep using contraception until menopause is confirmed, 12 months after your last period, or until roughly age 50 to 55 if hormonal methods are hiding your cycle. Most methods remain safe after 40; the main question is whether estrogen-containing methods still suit you.

Why it still matters

The CDC’s 2024 practice recommendations are direct: contraceptive protection is still needed for women over 44 who want to avoid pregnancy. The median age at which natural fertility is definitively lost is 41, but it ranges up to 51, and the median age of menopause is about 51 with a range of 40 to 60. There is no way to know from the outside which side of that range you are on.

A review in Maturitas notes that although the absolute risk of pregnancy is lower in perimenopause, unintended pregnancies occur in a similar proportion of all pregnancies as in younger women, and they carry higher risks of miscarriage, chromosomal abnormalities and maternal complications. The CDC lists hemorrhage, blood clots and death among the maternal risks of pregnancy at advanced reproductive age. Spontaneous pregnancies have been reported in women as old as 59.

Which methods US guidance favors after 40

The CDC’s US Medical Eligibility Criteria rate each method for each medical condition on a 1 to 4 scale: 1 means no restriction, 2 means advantages generally outweigh risks, 3 means risks usually outweigh advantages, and 4 means unacceptable health risk.

Method	Category at age 40+	Notes
Copper IUD	1	Hormone-free; can make periods heavier
Hormonal (levonorgestrel) IUD	1	Also treats heavy bleeding; approved for 3 to 8 years depending on brand
Implant	1	Approved for up to 5 years
Injection (DMPA)	1	Given every 3 months
Progestin-only pill	1	One type available without prescription
Combined pill, patch or ring	2	Category 3 or 4 with smoking, hypertension or migraine with aura
Sterilization	Not rated by age	The most common method among US women in this age group

ACOG describes the IUD and implant as the most effective reversible methods, with no effect on future fertility once removed. A review in Menopause concludes that intrauterine contraception is safe for midlife women with few exceptions, that progestin-only methods are safe for most because they do not raise cardiovascular risk, and that combined methods are safe for midlife women who do not have cardiovascular risk factors.

When estrogen-containing methods are off the table

Combined hormonal contraception carries a small clot and cardiovascular risk that rises with age and with other risk factors. The US MEC assigns combined methods:

• Category 3 (risks usually outweigh benefits) for smokers aged 35 and older who smoke fewer than 15 cigarettes a day, and for women with adequately controlled hypertension or blood pressure of 140 to 159 over 90 to 99.
• Category 4 (unacceptable risk) for smokers aged 35 and older who smoke 15 or more cigarettes a day, for blood pressure of 160 or higher over 100 or higher, and for migraine with aura.

Migraine without aura is category 2. If any of these applies to you, progestin-only methods and IUDs remain category 1 and are the usual recommendation. The Maturitas review puts it simply: no method is contraindicated by age alone, but estrogen-containing methods should be reserved for women without cardiovascular or thrombotic risk factors.

Benefits beyond contraception

Perimenopause is one of the few times when contraception can treat the symptoms of the stage itself.

Heavy or irregular bleeding. The levonorgestrel IUD is FDA-approved for heavy menstrual bleeding, a frequent complaint in perimenopause. Combined methods regulate and lighten periods.

Hot flashes and night sweats. The Menopause Society notes that in women still having cycles, menopausal hormone therapy can cause nuisance breakthrough bleeding, so continuous combined contraceptives (pill, patch or ring) are frequently used instead, especially when birth control is also needed. An alternative is a levonorgestrel IUD plus estrogen therapy.

Lining protection during the switch. The hormonal IUD can supply the progestin component of hormone therapy for a woman using estrogen, protecting the uterine lining. This use is off-label in the US but well described in the literature.

Cancer risk. The Menopause review lists decreased cancer risk among the non-contraceptive benefits of hormonal contraception in this age group.

Our guide to what perimenopause is covers the symptom picture these methods can help with.

When to stop

Because there is no reliable test for the end of fertility, clinicians use time and age.

If you can see your periods. The commonly cited rule, summarized in the Maturitas review, is to continue contraception until you have had no period for 2 years if you are under 50, or for 1 year if you are 50 or older. The Menopause Society’s patient guidance gives the simpler version: until menopause is confirmed at 1 year after the final period.

If a hormonal method hides your periods. The CDC notes that both ACOG and The Menopause Society recommend continuing contraception until menopause or until age 50 to 55. In practice many clinicians suggest switching from a combined method to a progestin-only method or IUD around 50 if cardiovascular risk is rising, then stopping altogether around 55.

What about an FSH test? The CDC states that no reliable laboratory tests are available to confirm the definitive loss of fertility and that FSH testing for this purpose might not be accurate. Some clinicians still use two elevated FSH values taken at least 2 weeks off hormonal methods as supporting evidence, but it is not definitive, which is why the age-based approach dominates.

Hormone therapy is not contraception

If you move from a contraceptive to menopausal hormone therapy for symptoms, you lose pregnancy protection. Hormone therapy doses do not suppress ovulation. The Menopause review notes that guidelines allow midlife women without contraindications to use contraception until menopause, at which point they may consider transitioning to hormone therapy. The transition should be a deliberate decision made with your clinician, not an accident of a refill.

When to see a clinician

• You are over 40 and have not reviewed your method in the past few years, particularly if you smoke, have high blood pressure or have migraine with aura
• You have heavy bleeding, bleeding between periods or after sex, or any bleeding after 12 months without a period
• You are soaking through a pad or tampon every hour for 2 or more hours in a row, especially with dizziness or shortness of breath: seek same-day care
• You have hot flashes or sleep disruption and want a method that treats both
• You think you may have reached menopause and want to plan when to stop

The symptom check can help you summarize symptoms before the visit. If your current clinician is not comfortable with perimenopausal care, see how to find a menopause specialist or search for an ob-gyn near you.